Nancy J. Cox

Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).

N. Cox, Y. Matsuoka, R. Donis, 2011, Virology.

Protection against virulent H5 avian influenza virus infection in chickens by an inactivated vaccine produced with recombinant vaccinia virus.

N. Cox, A. Kendal, M. Shaw, 1988, Vaccine.

Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60.

N. Cox, A. Kendal, H. Maassab, 1979, Virology.

Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.

N. Cox, R. Couch, A. Kendal, 1996, The Journal of infectious diseases.

Laboratory properties of cold-adapted influenza B live vaccine strains developed in the US and USSR, and their B/Ann Arbor/1/86 cold-adapted reassortant vaccine candidates.

N. Cox, A. Kendal, H. Maassab, 1990, Vaccine.

Biological, genetic and biochemical characterization of a cold-adapted recombinant A/Victoria/3/75 virus and its evaluation in volunteers.

N. Cox, B. Murphy, A. Kendal, 1977, Developments in biological standardization.